Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270512 · ClinicalTrials.gov registry record · NA
Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions
A NA study of Skin Lesion, sponsored by R2 Dermatology.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 4
- Study locations
NCT05270512 is a NA study of Skin Lesion that has completed, run by R2 Dermatology. The registered enrollment target is 88 participants, below the 1,769-participant average among 3 other Skin Lesion trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT05270512, a NA study of Skin Lesion, has completed, sponsored by R2 Dermatology.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate whether the Dermal Cooling System can be used to elicit an improvement in the cosmetic appearance or physical symptoms of common skin conditions.
Conditions Studied
Interventions
- DEVICE Dermal Cooling System
Study Locations (4)
California
- West Coast Research - Dublin
Illinois
- Oak Dermatology - Naperville
New York
- Skin Search of Rochester, Inc. - Rochester
North Carolina
- Dermatology, Laser and Vein Specialists of the Carolinas - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2021-12-10 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05270512
The ClinicalTrials.gov registry entry for NCT05270512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,769-participant average among 3 other Skin Lesion trials with a reported enrollment target (95% lower). The listed sponsor is R2 Dermatology, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Lesion appearing as the primary indexed condition, and to 1 intervention - of which Dermal Cooling System is the first listed.
NCT05270512 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT05270512 about?
NCT05270512 is a clinical study titled "Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions". The purpose of this study is to evaluate whether the Dermal Cooling System can be used to elicit an improvement in the cosmetic appearance or physical symptoms of common skin conditions.
What is the current status of trial NCT05270512?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2021-12-10. Estimated completion is 2023-11-01.
What conditions does trial NCT05270512 study?
This clinical trial studies the following conditions: Skin Lesion.
What interventions are being tested in trial NCT05270512?
The interventions under investigation include: Dermal Cooling System (DEVICE).
Who is sponsoring clinical trial NCT05270512?
This trial is sponsored by R2 Dermatology, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05270512 being conducted?
This trial has 4 study locations across California, Illinois, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.